Role of poly (ADP-ribose) polymerase-1 and cytokines in acute renal injury in elderly Chinese patients with diabetes mellitus

por Cao L, Liu Y, Zhang L, Wei YF
Publicado 2017

Pharmacological Poly (ADP-Ribose) Polymerase Inhibitors Decrease Mycobacterium tuberculosis Survival in Human Macrophages

por Cassandra L. R. van Doorn, Sanne A. M. Steenbergen, Kimberley V. Walburg, Tom H. M. Ottenhoff
Publicado 2021

Lipoic Acid Decreases the Expression of Poly ADP-Ribose Polymerase and Inhibits Apoptosis in Diabetic Rats

por Chen J, Li Q
Publicado 2020

PARP Inhibitors in Combination with Radiotherapy: To Do or Not to Do?

por Amelia Barcellini, Pierre Loap, Kazutoshi Murata, Riccardo Villa, Youlia Kirova, Noriyuki Okonogi, Ester Orlandi
Publicado 2021

Update on Poly ADP-Ribose Polymerase Inhibitors in Ovarian Cancer With Non-BRCA Mutations

por Qin Xu, Zhengyu Li
Publicado 2021

Potential role of nicotinamide analogues against SARS-COV-2 target proteins

por Mandeep Kumar Arora, Parul Grover, Syed Mohammed Basheeruddin Asdaq, Lovekesh Mehta, Ritu Tomar, Mohd. Imran, Anuj Pathak, Ashok Jangra, Jagannath Sahoo, Abdulhakeem S. Alamri, Walaa F. Alsanie, Majid Alhomrani
Publicado 2021

Mechanisms of Nucleosome Reorganization by PARP1

por Natalya V. Maluchenko, Dmitry K. Nilov, Sergey V. Pushkarev, Elena Y. Kotova, Nadezhda S. Gerasimova, Mikhail P. Kirpichnikov, Marie-France Langelier, John M. Pascal, Md. Sohail Akhtar, Alexey V. Feofanov, Vasily M. Studitsky
Publicado 2021

Role of PARP in TNBC: Mechanism of Inhibition, Clinical Applications, and Resistance

por Desh Deepak Singh, Amna Parveen, Dharmendra Kumar Yadav
Publicado 2021

PARP Inhibitors: An Innovative Approach to the Treatment of Inflammation and Metabolic Disorders in Sepsis

por Wasyluk W, Zwolak A
Publicado 2021

High Poly(ADP-Ribose) Polymerase Expression Does Relate to Poor Survival in Solid Cancers: A Systematic Review and Meta-Analysis

por Nishant Thakur, Kwangil Yim, Jamshid Abdul-Ghafar, Kyung Jin Seo, Yosep Chong
Publicado 2021